BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22515642)

  • 21. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
    Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
    World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
    Liu F; Zhang Y; Peng Z; Gao H; Xu L; Chen M
    J Transl Med; 2012 Jul; 10():135. PubMed ID: 22747650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cytoskeleton regulatory protein Mena in human hepatocellular carcinoma and its prognostic significance.
    Hu K; Wang J; Yao Z; Liu B; Lin Y; Liu L; Xu L
    Med Oncol; 2014 May; 31(5):939. PubMed ID: 24683008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of SOX-1 expression in human hepatocelluar cancer.
    Lou J; Zhang K; Chen J; Gao Y; Wang R; Chen LB
    Int J Clin Exp Pathol; 2015; 8(5):5411-8. PubMed ID: 26191244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex-determination gene SRY potentially associates with poor prognosis but not sex bias in hepatocellular carcinoma.
    Xue TC; Zhang L; Ren ZG; Chen RX; Cui JF; Ge NL; Ye SL
    Dig Dis Sci; 2015 Feb; 60(2):427-35. PubMed ID: 25274159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth arrest-specific homeobox is associated with poor survival in patients with hepatocellular carcinoma.
    Zhou P; Chen Z; Chang RM; Jiang W; Wu LL; Wang ZM
    Med Oncol; 2012 Dec; 29(5):3063-9. PubMed ID: 22644917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
    Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
    Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma.
    OuYang HY; Xu J; Luo J; Zou RH; Chen K; Le Y; Zhang YF; Wei W; Guo RP; Shi M
    Hepatology; 2016 Apr; 63(4):1227-39. PubMed ID: 26660154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
    Jia SW; Fu S; Wang F; Shao Q; Huang HB; Shao JY
    World J Gastroenterol; 2014 Jan; 20(1):183-92. PubMed ID: 24415871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
    Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
    World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
    Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-level expression of periostin is closely related to metastatic potential and poor prognosis of hepatocellular carcinoma.
    Lv Y; Wang W; Jia WD; Sun QK; Li JS; Ma JL; Liu WB; Zhou HC; Ge YS; Yu JH; Xia HH; Xu GL
    Med Oncol; 2013 Mar; 30(1):385. PubMed ID: 23275141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-level expression of HOXB13 is closely associated with tumor angiogenesis and poor prognosis of hepatocellular carcinoma.
    Zhu JY; Sun QK; Wang W; Jia WD
    Int J Clin Exp Pathol; 2014; 7(6):2925-33. PubMed ID: 25031711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of TRIM3 is associated with poor prognosis in patients with primary hepatocellular carcinoma.
    Chao J; Zhang XF; Pan QZ; Zhao JJ; Jiang SS; Wang Y; Zhang JH; Xia JC
    Med Oncol; 2014 Aug; 31(8):102. PubMed ID: 24994609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Low Zinc Finger Antiviral Protein Expression with Progression and Poor Survival of Patients with Hepatocellular Carcinoma.
    Liu Y; Hu C; Zhu WB; Xu WX; Li ZY; Lin Y; Cai J; Liang JK; Zhu X; Gao ZL; Yan GM; Peng L
    Cell Physiol Biochem; 2018; 49(3):1007-1018. PubMed ID: 30196292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
    Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
    Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma.
    Wang R; Yu Z; Chen F; Liao C; Wang Q; Huang X
    Hum Pathol; 2018 Mar; 73():114-121. PubMed ID: 29288040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.